A University of Liverpool research team has published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy. Pancreatic cancer is one of the leading causes of cancer death and curren ...
Most media attention is awarded to cancer's success stories - new treatment breakthroughs are celebrated as researchers (and journalists) search for an exciting new "cure" for cancer. But what happens after these innovations hit the news? And who is ...
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells. Although both drugs were previously tested as sing ...
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease, ...
Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream. Mitchell believes the technique will be transformative in provid ...
Results of a Phase 2, open-label, dose-confirmation study of eribulin in combination with capecitabine, suggests that this therapy is efficacious in women with metastatic breast cancer (overall response rate 42.9% and clinical benefit rate 57.1%), w ...
University of Technology Sydney (UTS) research crunching vast amounts of data on childhood cancer to better tailor treatment is one step closer to assisting clinicians as the collaboration with the Kids Research Institute at The Children's Hospital ...
Scientists at the University of Manchester have discovered a potential weakness in cancer’s ability to return or become resistant to treatment, by targeting the ‘fuel’ part of stem cells which allows tumors to grow. Cancer stem cells are particularl ...
Shutting Down Energy to Brain Cancer MRI image of a glioblastoma multiforme. (Source: Wikimedia/The Armed Forces Institute of Pathology) A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer ...
Vivolux, a pharmaceutical company specialized in cancer treatment, announced that the FDA has granted clearance to proceed with VLX1570 to clinical phase 1/2 for treatment against relapsed and/or refractory multiple myeloma. Researchers at Vivolux h ...
